Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
InMode Ltd. INMD
$33.26
-$0.98 (-2.95%)
На 18:01, 12 мая 2023
+92.42%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
2828564009.00000000
-
week52high
41.84
-
week52low
20.60
-
Revenue
454271000
-
P/E TTM
17
-
Beta
2.07086600
-
EPS
1.91000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 июл 2023 г. в 12:30
Описание компании
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | Buy | 29 июл 2022 г. |
| Canaccord Genuity | Buy | Buy | 30 июн 2022 г. |
| Needham | Buy | Buy | 03 мая 2022 г. |
| Needham | Buy | Buy | 11 февр 2022 г. |
| Canaccord Genuity | Buy | Buy | 27 окт 2021 г. |
| Jefferies | Buy | 12 окт 2022 г. | |
| Barclays | Overweight | 21 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
More Likely to 5X First: Teladoc vs. InMode
The Motley Fool
10 мая 2023 г. в 05:30
Teladoc has recently put the focus on the path to profitability. InMode has delivered gains in earnings over time.
2 Magnificent Growth Stocks You Can Buy With $150 Right Now
The Motley Fool
10 мая 2023 г. в 05:11
Investing in growth stocks can be far less risky if you make smaller, more frequent purchases of your favorite companies. Axsome Therapeutics is a commercial-stage drugmaker that recently launched a new treatment for depression, one of the most commonly diagnosed disabilities.
1 Soaring Growth Stock That's Still an Unbeatable Bargain
The Motley Fool
07 мая 2023 г. в 05:17
InMode is a medical device maker gaining a share of the rapidly growing market for minimally invasive cosmetic procedures. Despite a tough period for making comparisons, InMode reported first-quarter sales that rose 23.5% year over year.
InMode: A Compelling Investment In The Fast-Growing Medical Aesthetics Market
Seeking Alpha
05 мая 2023 г. в 23:26
InMode is a leading provider of innovative, energy-based, and minimally invasive aesthetic and medical treatment solutions. The company has seen explosive growth on both the top line and bottom line with revenues and EBITDA growing at a 46% and 58% CAGR, respectively.
Why InMode Stock Plummeted by 10% on Tuesday
The Motley Fool
02 мая 2023 г. в 18:30
The medical aesthetics specialist notched solid revenue and profitability beats in its first quarter. There was a big catch to its performance, however.